Beijing Hotgen Biotech Co.Ltd(688068) : announcement of the resolution of the first extraordinary general meeting of shareholders in 2022

Securities code: Beijing Hotgen Biotech Co.Ltd(688068) securities abbreviation: Beijing Hotgen Biotech Co.Ltd(688068) Announcement No.: 2022011 Beijing Beijing Hotgen Biotech Co.Ltd(688068) Technology Co., Ltd

Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and bear legal responsibility for the authenticity, accuracy and integrity of the contents according to law. Important content tips: whether there is a proposal rejected at this meeting: none. Convening and attendance of the meeting

(I) time of shareholders’ meeting: March 3, 2022

(II) place of the general meeting of shareholders: meeting room (III) on the fifth floor, No. 25 Heshun street, Daxing District, Beijing ordinary shareholders, shareholders with special voting rights, preferred shareholders whose voting rights have been restored and the number of voting rights they hold:

1. Number of shareholders and proxies attending the meeting 11

Number of ordinary shareholders 12

2. The number of voting rights held by shareholders attending the meeting is 8196205

Number of voting rights held by ordinary shareholders 8196205

3. The ratio of the number of voting rights held by shareholders attending the meeting to the number of voting rights of the company

131779 cases (%)

Proportion of the number of voting rights held by ordinary shareholders in the number of voting rights of the company (%) 131779

(IV) whether the voting method complies with the provisions of the company law and the articles of association, the chairmanship of the general meeting, etc. 1. Voting method: the meeting adopts a combination of on-site and online voting. 2. Convening and presiding over: the meeting was convened by the board of directors of the company, and the chairman, Mr. Lin Changqing, presided over the meeting. The convening procedures and voting procedures of this meeting comply with the provisions of the company law and the articles of association.

(V) attendance of directors, supervisors and Secretary of the board of directors of the company

1. There are 9 directors in office and 9 present, and explain the directors who are not present and their reasons one by one;

2. There are 3 in-service supervisors of the company and 3 present, explaining the supervisors who did not attend and their reasons one by one;

3. Shi Yongzhan, Secretary of the board of directors, attended the meeting; Senior manager Sun Haifeng attended the meeting as a nonvoting delegate. 2、 Deliberation of the proposal 4. Non cumulative voting proposal 1. Title of the proposal: proposal on the establishment of holding subsidiaries and related party transactions

Outcome: adopted

Voting:

Agree against abstention

Proportion of votes of shareholders (%) proportion of votes (%)

Common stock 81962051000000 0.0000 —

(I) if major matters are involved, the voting situation of less than 5% shareholders shall be explained

The motion agrees to oppose abstention

No. name of proposal proportion of votes (%) proportion of votes (%)

1. Regulations on the establishment of control center

Joint stock subsidiary and proposal on 29214561000000 0.0000 – joint stock transaction

(II) explanation on the voting of proposals

The above proposal is an ordinary resolution, which has been approved by more than half of the total number of effective voting shares held by shareholders or shareholder representatives attending the meeting; The votes of small and medium-sized investors were counted separately.

Related shareholders Mr. Lin Changqing and Beijing Tongcheng rejing investment management partnership (limited partnership) avoided voting on proposal 1. 3、 Witness by lawyers 1. Law firm witnessed by this shareholders’ meeting: Beijing Kangda law firm

Lawyer: Lu Tongtong, Xiao Xiaobao 2. Lawyer’s Witness conclusion:

In conclusion, our lawyers believe that the convening and convening procedures of the company’s meeting comply with the provisions of the company law, rules, implementation rules and other laws, regulations, normative documents and the articles of Association; The qualifications of the participants and the convener of the meeting are legal and valid; The proposals considered at this meeting are legal and effective; The voting procedures of this meeting comply with the provisions of relevant laws, regulations and the articles of association, and the voting results are legal and valid. It is hereby announced.

Board of directors of Beijing Beijing Hotgen Biotech Co.Ltd(688068) Technology Co., Ltd. March 4, 2022

- Advertisment -